'Right Care, Right Time - An evaluation using an electroceutical treatment to determine the clinical outcomes in a large NHS Trust’ poster presented at Wounds UK
Published : 20/11/2017
Significant wound size reduction and healing. Within the 20 week period following treatment, 84% of all wounds healed and 100% of all wounds < 1 year old prior to treatment healed. Using Accel-Heal® can significantly improve clinical outcomes for patients when used alongside standard therapy. Development of a pathway to be incorporated into Trusts’ formularies and guidelines provides clinicians with the appropriate tool to ensure the right care is given at the right time. The incorporation of an appropriate pathway also ensures control of spend and unwanted variance in treatment.
View the poster here:
- Right Care, Right Time - An evaluation using an electroceutical treatment* to determine the clinical outcomes in a large NHS Trust (pdf)
Poster presentation by Nicola Turner, Tissue Viability Nurse in a large community NHS partnership Trust & Liz Ovens, Independent Tissue Viability Nurse and Associate Lecturer Bucks New University, Wounds UK November 2017
Please send your comments via Twitter